Traumatic Brain Injury, or TBI, has been on the rise in the United States. TBI has gained the national spotlight, especially in the sports arena in both amateur and professional organizations (remember Will Smith’s movie Concussion (2015)?). TBI attribtues to 30% of all injury-related deaths in the United States. 138 people in the United States pass away from TBI-related injuries every day. Those who are lucky enough to survive from a TBI can be effected for the short-term with headaches and dizziness; but sometimes, they face a life-time of disability. Between 2001 and 2010, emergency room visits related to TBI increased by 70% (Source: Centers for Disease Control and Prevention – CDC.gov).
Researchers at the University of Miami has recognized this growing epidemic. With a $16 million grant from Scythian Biosciences, Dr. Gillian Hotz and Michael Hoffer of The Miami Project to Cure Paralysis and the University of Miami’s Miller School of Medicine are embarking on a five-year study surrounding cannabidiol (CBD) as treatment for TBI.